Deininger, M., Radich, J., Burn, T. C., Huber, R., Paranagama, D., & Verstovsek, S. (2015). The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis. Blood.
Style de citation ChicagoDeininger, Michael, Jerald Radich, Timothy C. Burn, Reid Huber, Dilan Paranagama, et Srdan Verstovsek. "The Effect of Long-term Ruxolitinib Treatment On JAK2p.V617F Allele Burden in Patients With Myelofibrosis." Blood 2015.
Style de citation MLADeininger, Michael, et al. "The Effect of Long-term Ruxolitinib Treatment On JAK2p.V617F Allele Burden in Patients With Myelofibrosis." Blood 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.